63
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease

, , , , , , , , , , & show all
Pages 1119-1124 | Published online: 10 Apr 2017

References

  • VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med201318734736522878278
  • BrusselleGGJoosGFBrackeKRNew insights into the immunology of chronic obstructive pulmonary diseaseLancet20113781015102621907865
  • FearyJRRodriguesLCSmithCJHubbardRBGibsonJEPrevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary careThorax20106595696220871122
  • ReedRMEberleinMGirgisRECoronary artery disease is under-diagnosed and under-treated in advanced lung diseaseAm J Med20121251228.e131228.e22
  • LechatPPackerMChalonSCucheratMArabTBoisselJPClinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomised trialsCirculation199898118411919743509
  • HjalmarsonAElmfeldtDHerlitzJEffect on mortality of metoprolol in acute myocardial infarction: a double-blind randomised trialLancet198128238276116950
  • NeefPAMcDonaldCFBurrellLMIrvingLBJohnsonDFSteinfortDPBeta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac diseaseIntern Med J2016461336134027813357
  • BhattSPWellsJMKinneyGLβ-Blockers are associated with a reduction in COPD exacerbationsThorax20167181426283710
  • RuttenFHIZuithoffNPHakEGrobbeeDEHoesAWBeta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseaseArch Intern Med201017088088720498416
  • ShortPMLipworthSIElderDHSchembriSLipworthBJEffect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyBMJ2011342d254921558357
  • SalpeterSROrmistonTMSalpeterEECardioselective beta-blockers for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20054CD003566
  • RabeKFHurdSAnzuetoAGlobal Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease – GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
  • IshikawaNHattoriNKohnoNKobayashiAHayamizuTJohnsonMAirway inflammation in Japanese COPD patients compared with smoking and nonsmoking controlsInt J Chron Obstruct Pulmon Dis20151018519225670894
  • Guideline of respiratory function tests: spirometry, flow-volume curve, diffusion capacity of the lungNihon Kokyuki Gakkai Zasshi2004Suppl156 Japanese
  • FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J1977116451648871704
  • VestboJEdwardsLDScanlonPDChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med20113651184119221991892
  • LothDWBrusselleGGLahousseLHofmanALeufkensHGStrickerBHβ-Adrenoceptor blockers and pulmonary function in the general population: The Rotterdam StudyBr J Clin Pharmacol20147719020023772842
  • MalerbaMMontuschiPRadaeliAPirisiMRole of beta-blockers in patients with COPD: current perspectiveDrug Discov Today20152012913525238736
  • Callaerts-VeghZEvansKLDudekulaNEffects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthmaProc Natl Acad Sci U S A20041014948495315069206
  • McGrawDWForbesSLMakJCTransgenic overexpression of beta (2)-adrenergic receptors in airway epithelial cells decreases bronchoconstrictionAm J Physiol Lung Cell Mol Physiol2000279L379L38910926562
  • NguyenLPOmoluabiOParraSChronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma modelAm J Respir Cell Mol Biol20083825626218096872
  • KestenSCelliBDecramerMLiuDTashkinDAdverse health consequences in COPD patients with rapid decline in FEV1–evidence from the UPLIFT trialRespir Res20111212921955733
  • AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA199427219149715057966841
  • NishimuraMMakitaHNagaiKAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012185445222016444
  • CasanovaCde TorresJPAguirre-JaimeAThe progression of chronic obstructive pulmonary disease is heterogeneous: The experience of the BODE cohortAm J Respir Crit Care Med20111841015102121836135
  • KimSJLeeJParkYSAge-related annual decline of lung function in patients with COPDInt J Chron Obstruct Pulmon Dis201511516026766907
  • TashkinDPLiNHalpinDAnnual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPDRespir Med20131071904191123972968